Displaying 2741 - 2760 of 5993
Contract Number Brand Code Brand Name Package Size Formulary Category Unit Price Strength Max. Reimbursable / Month Drug Contract Start Date Drug Contract End Date Restrict To Ophthalmologist Restrict To Pulmonologist Status Description Max Repeats
42 4151L BROMOPRIN 2.5MG TAB (JLP) BROMOCRIPTINE 100'S A 0.38 2.5MG 90 2026-04-01 No No 6
40 41811 MABTHERA 10MG/ML INJ (ROC/AHI) RITUXIMAB 100MG VIAL C 1,391.78 10MG/ML 0 2022-04-01 2024-03-31 0
41 41811 MABTHERA 10MG/ML INJ (ROC) RITUXIMAB (BQ) 100MG VIAL BQ 1391.7819 10MG/ML 0 2024-04-01 2026-03-31 0
40 41817 REMICADE 100MG INJ (JAC/STO) INFLIXIMAB 20ML VIAL C 1,460.17 100MG 0 2022-04-01 2024-03-31 0
41 41817 REMICADE 100MG INJ (JAC) INFLIXIMAB (C) 20ML VIAL C 1460.1749 100MG 0 2024-04-01 2026-03-31 0
42 41817 REMICADE 100MG INJ (JAC) INFLIXIMAB 20ML VIAL BQ 1,460.17 100MG 0 2026-04-01 No No 0
40 4181A AVASTIN 25MG/ML INJ (ROC/AHI) BEVACIZUMAB 100MG VIAL C 1,003.06 25MG/ML 0 2022-04-01 2024-03-31 0
41 4181A AVASTIN 25MG/ML INJ (ROC) BEVACIZUMAB (C) 100MG VIAL C 1003.0616 25MG/ML 0 2024-04-01 2026-03-31 0
42 4181A AVASTIN 25MG/ML INJ (ROC) BEVACIZUMAB 100MG VIAL C 1,003.06 25MG/ML 0 2026-04-01 No No 0
42 4181AM MABTHERA 10MG/ML INJ (ROC) RITUXIMAB 2X100MG BQ 1,252.60 10MG/ML 0 2026-04-01 No No 0
40 4181B AVASTIN 25MG/ML INJ (ROC/AHI) BEVACIZUMAB 400MG VIAL C 4,012.25 25MG/ML 0 2022-04-01 2024-03-31 0
41 4181B AVASTIN 25MG/ML INJ (ROC) BEVACIZUMAB (C) 400MG VIAL C 4012.2462 25MG/ML 0 2024-04-01 2026-03-31 0
42 4181B AVASTIN 25MG/ML INJ (ROC) BEVACIZUMAB 400MG VIAL C 4,012.25 25MG/ML 0 2026-04-01 No No 0
40 4181BA REDITUX 10MG/ML INJ (DRL/AAL) RITUXIMAB 50ML C 383.56 10MG/ML 0 2022-04-01 2024-03-31 0
40 4181BB MABTHERA 10MG/ML INJ (ROC/AHI) RITUXIMAB 50ML C 3,479.45 10MG/ML 0 2022-04-01 2024-03-31 0
41 4181BB MABTHERA 10MG/ML INJ (ROC) RITUXIMA (BQ) 50ML BQ 3479.4547 10MG/ML 0 2024-04-01 2026-03-31 0
40 4181BC MABTHERA SC 1400MG INJ (ROC/AHI) RITUXIMAB 11.7ML C 4,392.81 1400MG 0 2022-04-01 2024-03-31 0
41 4181BC MABTHERA SC 1400MG INJ (ROC) RITUXIMAB (BQ) 11.7ML BQ 4392.8116 1400MG 0 2024-04-01 2026-03-31 0
42 4181BC MABTHERA SC 1400MG INJ (ROC) RITUXIMAB 11.7ML BQ 4,392.81 1400MG 0 2026-04-01 No No 0
40 4181BE KEYTRUDA 25MG/ML INJ (MSD/STO) PEMBROLIZUMAB 4ML VIAL C 9,766.50 25MG/ML 0 2022-04-01 2024-03-31 0